A conceptual framework for managing iTTP

In this issue of Blood, Cuker et al propose revised outcome definitions for immune thrombotic thrombocytopenic purpura (iTTP) that incorporate mechanistic insights that will better inform treatment choices of existing and novel therapeutics.(1)

Automated summary

The revised outcome definitions for iTTP proposed in this article incorporate mechanistic insights and will better inform treatment choices of existing and novel therapeutics.